Cancer Commons News and Events

Happy Holidays from Cancer Commons

December 12, 2018

The holiday season is an excellent time to reflect on the successes of the past year while looking forward to opportunities in the rapidly approaching new year. We want to express our deepest appreciation to the Cancer Commons community; everyone’s involvement and support have been integral to our progress and success this year. Our mission of leveraging the world’s best cancer knowledge to help advanced… Read more »

Image credit: Caroline Davis2010

Marty Tenenbaum to Speak at NYC Oncology Investor Conference

October 22, 2018

Cancer Commons founder Marty Tenenbaum, PhD, will speak at the NYC Oncology Investor Conference on October 30. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments. Read the synopsis of Marty’s presentation, “Can AI Cure Cancer?”: No one knows the optimal way to treat any cancer with currently available therapies.… Read more »

Tomstock: 5 Years of “Rockin’ for a Cure”

August 29, 2018

Last Saturday, Cancer Commons joined nearly 2,000 guests in Independence, MO, for a day full of music and celebration. Called Tomstock, this private, annual music festival raised funds for the H8 Cancer Foundation, a generous supporter of our organization. Cancer Commons received $100,000 of the proceeds from Tomstock 2018. Tomstock began five years ago when longtime friends Tom and Carman Duvall, and Kiers and Steve… Read more »

Erika Vial Monteverdi, Executive Director of Cancer Commons

Cancer Commons Welcomes New Executive Director Erika Vial Monteverdi

July 5, 2018

Cancer Commons is happy to announce that Erika Vial Monteverdi has accepted the new position of Executive Director. Erika has played a central role at the organization since 2016. As Executive Director, she is now responsible for overseeing the growth and operations of Cancer Commons, one of Silicon Valley’s only nonprofits focused on serving cancer patients globally through aligning incentives around the patient to… Read more »

Biomarker for lung cancer

Marty Tenenbaum Speaks at MIT/Washington University Conference on Biomedical Innovation

June 1, 2018

Cancer Commons founder Marty Tenenbaum, Ph.D., spoke on May 31 at Washington University in St. Louis during an invitation-only conference focused on new approaches to biomedical innovation. Marty, who founded Cancer Commons after his own battle with melanoma, participated in the “Opportunities and Challenges in Oncology Therapeutic Development” session, which explored promising new innovations that have not yet received the attention they merit. During the… Read more »

Marty Tenenbaum to Speak at Stanford AI Salon on May 11

May 10, 2018

Cancer Commons founder Marty Tenenbaum, Ph.D., will speak May 11 at the Stanford AI Salon, a regular event hosted by the Stanford University Artificial Intelligence Laboratory. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments in a talk titled “How can AI cure cancer?” According to the event website, “AI… Read more »

Marty Tenenbaum to Speak at Bio-IT World Conference on May 16

April 13, 2018

Cancer Commons founder Marty Tenenbaum, Ph.D., will speak at the upcoming Bio-IT World Conference & Expo in Boston, which runs May 15 to 18. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments. Read the synopsis of Marty’s presentation, entitled “Can AI Beat Cancer?“: AI can beat go and drive cars, but can… Read more »

Marty Tenenbaum to Speak at Bridging Clinical Collaborative on April 4

March 29, 2018

Cancer Commons founder Marty Tenenbaum, PhD, will speak next week at the Bridging Clinical Research & Clinical Health Care Collaborative in National Harbor, Maryland. His presentation will be featured in a session focused on precision oncology, which runs from 3:30 to 5:00 pm on Wednesday April 4. The Bridging Clinical Research & Clinical Health Care Collaborative is “the only forum where clinical research and health care… Read more »

Cancer Commons Founder and Medical Director Discuss the Future of Precision Medicine

February 16, 2018

A presentation by Cancer Commons founder Marty Tenenbaum, PhD, was well-received last month at the Precision Medicine World Conference (PMWC) in Silicon Valley. His talk, “How AI will Cure Cancer,” discussed the role of artificial intelligence in finding better cancer treatments. In a separate event at the same conference, Cancer Commons medical director Kevin Knopf, MD, spoke about the future of personalized medicine as part of a panel… Read more »

Marty Tenenbaum to Speak at Precision Medicine World Conference on Jan 23

January 11, 2018

Cancer Commons founder Marty Tenenbaum, Ph.D., will speak at the upcoming Precision Medicine World Conference (PMWC) in Silicon Valley, which runs Jan 22–24. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments. Read the synopsis of Marty’s presentation, entitled “How AI will Cure Cancer”: From an AI perspective, finding effective treatments for cancer… Read more »